CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-30 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +2,000 | $0.61 | $1K | 529,981 |
| 2023-03-30 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −2,000 | $16.01 | $32K | 527,981 |
| 2023-03-30 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,000 | 231,821 | ||
| 2023-03-30 | Harris Todd Chief Executive Officer | Option exercise | +2,407 | $2.25 | $5K | 1,703,683 |
| 2023-03-30 | Harris Todd Chief Executive Officer | Sale | −2,407 | $16.02 | $39K | 1,701,276 |
| 2023-03-30 | Harris Todd Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −2,407 | 400,037 | ||
| 2023-03-29 | Harris Todd Chief Executive Officer | Option exercise | +1,420 | $2.25 | $3K | 1,702,696 |
| 2023-03-29 | Harris Todd Chief Executive Officer | Sale | −1,420 | $16.18 | $23K | 1,701,276 |
| 2023-03-29 | Harris Todd Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −1,420 | 402,444 | ||
| 2023-03-29 | Bensen Daniel Chief Operating Officer | Option exercise | +2,187 | $0.61 | $1K | 530,168 |
| 2023-03-29 | Bensen Daniel Chief Operating Officer | Sale | −2,187 | $16.21 | $35K | 527,981 |
| 2023-03-29 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −2,187 | 233,821 | ||
| 2023-03-28 | Bensen Daniel Chief Operating Officer | Option exercise | +3,346 | $0.61 | $2K | 531,327 |
| 2023-03-28 | Bensen Daniel Chief Operating Officer | Sale | −3,346 | $16.00 | $54K | 527,981 |
| 2023-03-28 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −3,346 | 236,008 | ||
| 2023-03-28 | Harris Todd Chief Executive Officer | Option exercise | +2,779 | $2.25 | $6K | 1,704,055 |
| 2023-03-28 | Harris Todd Chief Executive Officer | Sale | −2,779 | $16.00 | $44K | 1,701,276 |
| 2023-03-28 | Harris Todd Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −2,779 | 403,864 | ||
| 2023-03-27 | Bensen Daniel Chief Operating Officer | Option exercise | +8,048 | $0.61 | $5K | 536,029 |
| 2023-03-27 | Bensen Daniel Chief Operating Officer | Sale | −8,048 | $16.00 | $129K | 527,981 |
Page 14 of 21 · 417 trades